Artelo Biosciences, Inc. (ARTL) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Artelo Biosciences, Inc. (ARTL) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.3M, listed on NASDAQ, employing roughly 6 people, carrying a beta of -0.14 to the broader market. Artelo Biosciences, Inc. Led by Gregory D. Gorgas, public since 2019-06-21.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ARTL as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →